These results suggest that individuals with the IL-1RN rs419598, or BCL2 rs2279115 polymorphisms showed a significant reduction in HNSCC risk progression, whereas those with the PIGR rs291102 dominance model had increased HNSCC risk. The gene discussed is PIGR; the disease is head and neck squamous cell carcinoma.